Comparative Genomic Hybridization Technique
Screening for chromosomal changes in solid tumors was long hindered by methodological problems encountered in standard cytogenetic analysis. Comparative genomic hybridization (CGH), a technique that emerged in 1992 (1 ) has proved to be a powerful tool for molecular cytogenetic analysis of neoplasms. The main prerequisite of the technique is DNA isolated from tumor samples. As no cell culture of tumor material is required, the technique has been successfully used to study fresh and frozen tissue samples, as well as archival formalin-fixed paraffin-embedded tissue samples. CGH allows to screen entire tumor genomes for gains and losses of DNA copy number, enabling consequent mapping of aberrations to chromosomal subregions. The technique is based on fluorescence in situ hybridization. Tumor and reference DNA are differentially labeled with fluorochromes (green and red, respectively) and mixed in equal amounts. The mixture is cohybridized competitively to a normal metaphase slide prepared from a lymphocyte cell culture of a normal healthy individual. After hybridization and washes, the chromosomes are counterstained with DAPI (blue) and slides are mounted with an antifading medium.
- Gene Amplification of c-erbB-2 Detected by FISH
- Melanoma Susceptibility Genes and Risk Assessment
- Liposomal Doxorubicin and nab-Paclitaxel: Nanoparticle Cancer Chemotherapy in Current Clinical Use
- Zebrafish as a Model for Pancreatic Cancer Research
- Analyzing Cell Cycle Checkpoints After Ionizing Radiation
- Large Scale Production of Recombinant Antibodies by Utilizing Cellulose-Binding Domains
- Metabolomic Profiling of Ovarian Carcinomas Using Mass Spectrometry
- Stability and Ubiquitination of the Tumor Suppressor Protein p53
- Utility of Fine-Needle Aspiration Biopsy for Prospective Analysis of Patients Undergoing Therapy for Metastatic Melanoma
- 如何提高U251的转染效率